Century Therapeutics, Inc. (IPSC) Operating margin 2022–2025
Century Therapeutics, Inc. (IPSC) operating margin by fiscal year — reported operating income divided by reported revenue.
-15.8%FY2025 · since FY2022: -2574.2% → -15.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.8% | +2080.7 pp |
| FY2024 | -2096.5% | +4460.4 pp |
| FY2023 | -6556.9% | -3982.7 pp |
| FY2022 | -2574.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice